SCHEMBL6284183

SCHEMBL6284183

CC(C(=O)NS(=O)(=O)CCN)c1ccc(C(=O)c2cccs2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.57
PTGS1 P23219 4/20 0.57
PTGS2 P35354 4/20 0.57
CYP2C9 P11712 3/20 0.57
ALDH1A1 P00352 2/20 0.57
LMNA P02545 1/20 0.57
KDM4E B2RXH2 1/20 0.57
RXFP1 Q9HBX9 1/20 0.57
HTT P42858 1/20 0.45
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
TSHR P16473 2/20 0.43
HPGDS O60760 1/20 0.42
CXCR1 P25024 2/20 0.40
CXCR2 P25025 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MAPT P10636 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15486630 0.89 HPGD (0.62) HPGDPTGS1PTGS2CYP2C9ALDH1A1
SCHEMBL27568101 0.80 HPGD (0.53) HPGDPTGS1PTGS2CYP2C9ALDH1A1
SCHEMBL12608941 0.79 HPGD (0.58) HPGDPTGS1PTGS2CYP2C9ALDH1A1
SCHEMBL11703606 0.78 HPGD (0.72) HPGDPTGS1PTGS2CYP2C9ALDH1A1
SCHEMBL13880085 0.78 HPGD (0.72) HPGDPTGS1PTGS2CYP2C9ALDH1A1
SCHEMBL28746061 0.76 HPGD (0.46) HPGDPTGS1PTGS2CYP2C9ALDH1A1
SCHEMBL27573450 0.76 CXCR1 (0.68) PTGS1PTGS2CYP2C9LMNATSHR
SCHEMBL11702513 0.75 HPGD (0.64) HPGDPTGS1PTGS2CYP2C9ALDH1A1
SCHEMBL11702523 0.75 HPGD (0.64) HPGDPTGS1PTGS2CYP2C9ALDH1A1
SCHEMBL18646081 0.75 HPGD (0.64) HPGDPTGS1PTGS2CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100368394-C N- (2-aryl-propionyl) -sulfonamides and pharmaceutical compositions containing them DOMPE SPA (IT) 2008-02-13 CN disclosed
US-6887903-B1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them DOMPE S.P.A. (IT) 2005-05-03 US disclosed
US-20030216392-A1 N - ( 2 - aryl - propionyl ) - sulfonamides and pharmaceutical preparations containing them DOMPE S.P.A. 2003-11-20 US disclosed
EP-1123276-B1 N-(2-ARYL-PROPIONYL)-SULFONAMIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM DOMPE SPA (IT) 2003-01-08 EP disclosed
CN-1324344-A N- (2-aryl-propionyl) -sulfonamides and pharmaceutical compositions containing them DOMPE SPA (IT) 2001-11-28 CN disclosed
EP-1123276-A1 N-(2-ARYL-PROPIONYL)-SULFONAMIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM Dompe' S.P.A. (IT) 2001-08-16 EP disclosed
WO-2000024710-A1 N-(2-ARYL-PROPIONYL)-SULFONAMIDES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM DOMPE' S.P.A. (IT) 2000-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216392-A1 N - ( 2 - aryl - propionyl ) - sulfonamides and pharmaceutical preparations containing them ELANE, MPO, FPR1 HPGD 497/4885PTGS1 29/4885PTGS2 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.